Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine With the Omission of Immune Globulin to Prevent Hepatitis B Transmission in Mother With High Viral Load: A Multi-Center, Prospective, Randomized and Open-Label Study

NCT03476083 is registered in ClinicalTrials.gov with New Discovery LLC as lead sponsor.

NCT NCT03476083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03476083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine With the Omission of Immune Globulin to Prevent Hepatitis B Transmission in Mother With High Viral Load: A Multi-Center, Prospective, Randomized and Open-Label Study
Lead sponsor
New Discovery LLC
Phase
Phase 4
Overall status
Unknown status
Start date
June 10, 2018
Completion date
May 31, 2024
Enrollment
280 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

birth defect, chronic infection, congenital malformation, hepatitis b infection, viremia